NEWS

​

Press Releases:  

​

Stramsen Biotech Inc. Announced Eleven New Natural Plant-based Drug / Medicine Candidates During its Board Members' Meeting (prnewswire.com)

​

Stramsen Biotech, Inc Announces $10 Million Series Financing Round at $807 Million Valuation (prnewswire.com)

​

Stramsen Biotech Joins Elite Class of Unicorns at $6.5 Billion Valuation and a Potential Reverse Merger Deal (prnewswire.com)

​

Stramsen Biotech Inc. Announced Military Veteran Mr. Chris White -(MBA) as The New President and Chief Financial Officer (prnewswire.com)

​

​Stramsen Biotech Announces Partnership with Nasdaq Private Market (NPM) | FirstWord Pharma

​

Stramsen Biotech Inc. Announced Mr. Joe Meuth as The Chairman of the Board of Directors and Mr. Peter Olsen as President and CFO (prnewswire.com)

​

​

Stramsen Biotech Inc. Appoints Dr. Kefas (Ph.D.) and Christopher Ramirez as Co-CEOs for The New Biotech Company (prnewswire.com)

​

​

Stramsen Biotech, Inc Announces Six Drug / Medicine Candidates Currently in Early-Stage Clinical Trials (prnewswire.com)

 

​

​Stramsen Biotech Announces Partnership with Nasdaq Private Market (NPM) | Prnewswire | starlocalmedia.com

​

​​

​Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS ("GEM")

​

​

​

​

​